207 related articles for article (PubMed ID: 9141209)
1. Highly attenuated modified vaccinia virus Ankara (MVA) as an effective recombinant vector: a murine tumor model.
Carroll MW; Overwijk WW; Chamberlain RS; Rosenberg SA; Moss B; Restifo NP
Vaccine; 1997 Mar; 15(4):387-94. PubMed ID: 9141209
[TBL] [Abstract][Full Text] [Related]
2. Harnessing the unique local immunostimulatory properties of modified vaccinia Ankara (MVA) virus to generate superior tumor-specific immune responses and antitumor activity in a diversified prime and boost vaccine regimen.
Hodge JW; Higgins J; Schlom J
Vaccine; 2009 Jul; 27(33):4475-82. PubMed ID: 19450631
[TBL] [Abstract][Full Text] [Related]
3. Active immunotherapy of cancer with a nonreplicating recombinant fowlpox virus encoding a model tumor-associated antigen.
Wang M; Bronte V; Chen PW; Gritz L; Panicali D; Rosenberg SA; Restifo NP
J Immunol; 1995 May; 154(9):4685-92. PubMed ID: 7722321
[TBL] [Abstract][Full Text] [Related]
4. IL-12 is an effective adjuvant to recombinant vaccinia virus-based tumor vaccines: enhancement by simultaneous B7-1 expression.
Rao JB; Chamberlain RS; Bronte V; Carroll MW; Irvine KR; Moss B; Rosenberg SA; Restifo NP
J Immunol; 1996 May; 156(9):3357-65. PubMed ID: 8617961
[TBL] [Abstract][Full Text] [Related]
5. Attenuated modified vaccinia virus Ankara can be used as an immunizing agent under conditions of preexisting immunity to the vector.
Ramírez JC; Gherardi MM; Rodríguez D; Esteban M
J Virol; 2000 Aug; 74(16):7651-5. PubMed ID: 10906221
[TBL] [Abstract][Full Text] [Related]
6. Biology of attenuated modified vaccinia virus Ankara recombinant vector in mice: virus fate and activation of B- and T-cell immune responses in comparison with the Western Reserve strain and advantages as a vaccine.
Ramírez JC; Gherardi MM; Esteban M
J Virol; 2000 Jan; 74(2):923-33. PubMed ID: 10623755
[TBL] [Abstract][Full Text] [Related]
7. Oral vaccination with modified vaccinia virus Ankara attached covalently to TMPEG-modified cationic liposomes overcomes pre-existing poxvirus immunity from recombinant vaccinia immunization.
Naito T; Kaneko Y; Kozbor D
J Gen Virol; 2007 Jan; 88(Pt 1):61-70. PubMed ID: 17170437
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic antitumor response after immunization with a recombinant adenovirus encoding a model tumor-associated antigen.
Chen PW; Wang M; Bronte V; Zhai Y; Rosenberg SA; Restifo NP
J Immunol; 1996 Jan; 156(1):224-31. PubMed ID: 8598466
[TBL] [Abstract][Full Text] [Related]
9. Improving recombinant MVA immune responses: potentiation of the immune responses to HIV-1 with MVA and DNA vectors expressing Env and the cytokines IL-12 and IFN-gamma.
Abaitua F; Rodríguez JR; Garzón A; Rodríguez D; Esteban M
Virus Res; 2006 Mar; 116(1-2):11-20. PubMed ID: 16214252
[TBL] [Abstract][Full Text] [Related]
10. Expanding the repertoire of Modified Vaccinia Ankara-based vaccine vectors via genetic complementation strategies.
Garber DA; O'Mara LA; Zhao J; Gangadhara S; An I; Feinberg MB
PLoS One; 2009; 4(5):e5445. PubMed ID: 19421328
[TBL] [Abstract][Full Text] [Related]
11. Costimulation enhances the active immunotherapy effect of recombinant anticancer vaccines.
Chamberlain RS; Carroll MW; Bronte V; Hwu P; Warren S; Yang JC; Nishimura M; Moss B; Rosenberg SA; Restifo NP
Cancer Res; 1996 Jun; 56(12):2832-6. PubMed ID: 8665522
[TBL] [Abstract][Full Text] [Related]
12. Attenuated recombinant vaccinia virus expressing oncofetal antigen (tumor-associated antigen) 5T4 induces active therapy of established tumors.
Mulryan K; Ryan MG; Myers KA; Shaw D; Wang W; Kingsman SM; Stern PL; Carroll MW
Mol Cancer Ther; 2002 Oct; 1(12):1129-37. PubMed ID: 12481437
[TBL] [Abstract][Full Text] [Related]
13. Modified vaccinia virus Ankara immunization protects against lethal challenge with recombinant vaccinia virus expressing murine interleukin-4.
McCurdy LH; Rutigliano JA; Johnson TR; Chen M; Graham BS
J Virol; 2004 Nov; 78(22):12471-9. PubMed ID: 15507634
[TBL] [Abstract][Full Text] [Related]
14. Co-expressing GP5 and M proteins under different promoters in recombinant modified vaccinia virus ankara (rMVA)-based vaccine vector enhanced the humoral and cellular immune responses of porcine reproductive and respiratory syndrome virus (PRRSV).
Zheng Q; Chen D; Li P; Bi Z; Cao R; Zhou B; Chen P
Virus Genes; 2007 Dec; 35(3):585-95. PubMed ID: 17922181
[TBL] [Abstract][Full Text] [Related]
15. Prime-boost immunization schedules based on influenza virus and vaccinia virus vectors potentiate cellular immune responses against human immunodeficiency virus Env protein systemically and in the genitorectal draining lymph nodes.
Gherardi MM; Nájera JL; Pérez-Jiménez E; Guerra S; García-Sastre A; Esteban M
J Virol; 2003 Jun; 77(12):7048-57. PubMed ID: 12768024
[TBL] [Abstract][Full Text] [Related]
16. Differences and similarities in viral life cycle progression and host cell physiology after infection of human dendritic cells with modified vaccinia virus Ankara and vaccinia virus.
Chahroudi A; Garber DA; Reeves P; Liu L; Kalman D; Feinberg MB
J Virol; 2006 Sep; 80(17):8469-81. PubMed ID: 16912297
[TBL] [Abstract][Full Text] [Related]
17. Immunogenicity of recombinant Modified Vaccinia Ankara following a single or multi-dose vaccine regimen in rhesus monkeys.
Grandpre LE; Duke-Cohan JS; Ewald BA; Devoy C; Barouch DH; Letvin NL; Reinherz EL; Baden LR; Dolin R; Seaman MS
Vaccine; 2009 Mar; 27(10):1549-56. PubMed ID: 19168105
[TBL] [Abstract][Full Text] [Related]
18. The highly attenuated vaccinia virus strain modified virus Ankara induces apoptosis in melanoma cells and allows bystander dendritic cells to generate a potent anti-tumoral immunity.
Greiner S; Humrich JY; Thuman P; Sauter B; Schuler G; Jenne L
Clin Exp Immunol; 2006 Nov; 146(2):344-53. PubMed ID: 17034588
[TBL] [Abstract][Full Text] [Related]
19. Modified vaccinia virus ankara recombinants are as potent as vaccinia recombinants in diversified prime and boost vaccine regimens to elicit therapeutic antitumor responses.
Hodge JW; Poole DJ; Aarts WM; Gómez Yafal A; Gritz L; Schlom J
Cancer Res; 2003 Nov; 63(22):7942-9. PubMed ID: 14633725
[TBL] [Abstract][Full Text] [Related]
20. Dendritic cells retrovirally transduced with a model antigen gene are therapeutically effective against established pulmonary metastases.
Specht JM; Wang G; Do MT; Lam JS; Royal RE; Reeves ME; Rosenberg SA; Hwu P
J Exp Med; 1997 Oct; 186(8):1213-21. PubMed ID: 9334360
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
